OUT COME OF VOTING AT 35TH AGM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Transgene Biotek held its 35th AGM on 30 December 2025 via video conferencing, where all 7 resolutions were approved. Out of 13,885 shareholders, only 50 cast votes (16,837,587 shares representing 22.22% of total 75,770,000 shares). Promoters voted with 16,409,902 shares (99.89% of their holding), while public non-institutional shareholders polled only 427,685 shares (0.72% of their holding) and no institutional shareholders participated. Six resolutions passed with near-unanimous support of 99.9998% in favour, including adoption of FY25 financial statements, re-appointment of Mr. Santhosh Kumar (retiring by rotation), three independent director re-appointments, and appointment of secretarial auditors for five years.
Routine governance outcome with no material surprises; however, the re-appointment of CMD Dr. K. Koteswara Rao saw relatively lower approval at 99.41%, with 23.39% of public non-institutional votes against it — worth noting for shareholders tracking management accountability. Low overall voting turnout (22.22%) is typical for small-cap companies and unlikely to affect the stock price.